ES2119779T3 - Solubilizacion de proteinas en formas activas. - Google Patents

Solubilizacion de proteinas en formas activas.

Info

Publication number
ES2119779T3
ES2119779T3 ES91915661T ES91915661T ES2119779T3 ES 2119779 T3 ES2119779 T3 ES 2119779T3 ES 91915661 T ES91915661 T ES 91915661T ES 91915661 T ES91915661 T ES 91915661T ES 2119779 T3 ES2119779 T3 ES 2119779T3
Authority
ES
Spain
Prior art keywords
protein
solubilization
proteins
active forms
refolding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91915661T
Other languages
English (en)
Spanish (es)
Inventor
Nirdosh Kumar Puri
Enzo Crivelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southern Cross Biotech Pty Ltd
Original Assignee
Southern Cross Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Cross Biotech Pty Ltd filed Critical Southern Cross Biotech Pty Ltd
Application granted granted Critical
Publication of ES2119779T3 publication Critical patent/ES2119779T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES91915661T 1990-09-05 1991-08-29 Solubilizacion de proteinas en formas activas. Expired - Lifetime ES2119779T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPK215990 1990-09-05

Publications (1)

Publication Number Publication Date
ES2119779T3 true ES2119779T3 (es) 1998-10-16

Family

ID=3774938

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91915661T Expired - Lifetime ES2119779T3 (es) 1990-09-05 1991-08-29 Solubilizacion de proteinas en formas activas.

Country Status (8)

Country Link
EP (1) EP0547102B1 (cg-RX-API-DMAC7.html)
AT (1) ATE168115T1 (cg-RX-API-DMAC7.html)
AU (1) AU664021B2 (cg-RX-API-DMAC7.html)
CA (1) CA2090701C (cg-RX-API-DMAC7.html)
DE (1) DE69129747T2 (cg-RX-API-DMAC7.html)
DK (1) DK0547102T3 (cg-RX-API-DMAC7.html)
ES (1) ES2119779T3 (cg-RX-API-DMAC7.html)
WO (1) WO1992004382A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1039330C (zh) * 1992-07-02 1998-07-29 皮特曼-穆尔有限公司 一种从含有无活性蛋白的溶液中回收生物活性形式重组蛋白的方法
DK44593D0 (da) * 1993-04-20 1993-04-20 Novo Nordisk As Fremgangsmaade til fremstilling af et polypeptid
US5856126A (en) * 1993-09-22 1999-01-05 Ajinomoto Co., Inc. Peptide having anti-thrombus activity and method of producing the same
ZA955789B (en) * 1994-07-15 1996-03-11 Novo Nordisk As A method of converting a hydrophobic derivative of a polypeptide into the native form
DE10309691B4 (de) * 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
MX2011013898A (es) * 2009-06-22 2012-05-22 Amgen Inc Proteínas replegadas que usan un estado de oxido-reduccion quimicamente controlado.
EP3660032B1 (en) 2009-06-25 2025-10-22 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
ES2813501T3 (es) 2013-02-12 2021-03-24 Bristol Myers Squibb Co Métodos de replegado de proteínas basados en filtración de flujo tangencial
ES2751735T3 (es) 2013-02-12 2020-04-01 Bristol Myers Squibb Co Métodos de replegado de proteínas a elevado pH
US9982012B2 (en) 2013-03-29 2018-05-29 Dr. Reddy's Laboratories Limited Refolding of granulocyte colony stimulating factor
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6079000A (ja) * 1983-10-04 1985-05-04 Takeda Chem Ind Ltd ヒトγ型インタ−フエロン単量体の製造法
WO1986003497A1 (en) * 1984-12-06 1986-06-19 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4766205A (en) * 1985-11-13 1988-08-23 Beatrice Companies, Inc. Method for isolation of recombinant polypeptides in biologically active forms
DE3611817A1 (de) * 1986-04-08 1987-10-15 Boehringer Mannheim Gmbh Verfahren zur renaturierung von proteinen
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
IL86090A (en) * 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
EP0295859B1 (en) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Production of proteins in active forms
KR890701759A (ko) * 1987-07-29 1989-12-21 스테이너 브이. 칸스태드 에스케리키아 콜라이내에서 발현된 사람 인터루킨-4의 정제방법
CA1340586C (en) * 1988-09-23 1999-06-08 Cetus Corporation Process for recovering microbially produced interferon-beta
DE3832898A1 (de) * 1988-09-28 1990-04-12 Boehringer Mannheim Gmbh Praeparat von in prokaryonten exprimiertem plasminogenaktivator
DE3901719A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur herstellung eines insulinvorlaeufers
DE3901718A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur renaturierung falscher rekombinanten von insulinvorlaeufern
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
DE4113750A1 (de) * 1991-04-26 1992-10-29 Boehringer Mannheim Gmbh Verbesserung der renaturierung bei der sekretion von disulfidverbrueckten proteinen

Also Published As

Publication number Publication date
WO1992004382A1 (en) 1992-03-19
EP0547102A4 (cg-RX-API-DMAC7.html) 1994-04-27
AU664021B2 (en) 1995-11-02
CA2090701A1 (en) 1992-03-10
DK0547102T3 (da) 1999-04-19
EP0547102B1 (en) 1998-07-08
DE69129747D1 (de) 1998-08-13
ATE168115T1 (de) 1998-07-15
AU8403591A (en) 1992-03-30
DE69129747T2 (de) 1998-11-12
CA2090701C (en) 2000-05-16
EP0547102A1 (en) 1993-06-23

Similar Documents

Publication Publication Date Title
NO882635L (no) Fremgangsmaate for fremstilling av proteiner i aktive former.
ATE104348T1 (de) O-glycosyliertes ifn-alpha.
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
DE69524864D1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
ATE210127T1 (de) 6-substituierte mycophenolsäurederivate mit immun suppressiver wirkung
TW200505478A (en) Immunoglobulin formulation and method of preparation thereof
DK0429570T3 (da) Osteoinducerende præparater
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
BR9709845B1 (pt) preparaÇço aquosa de insulina, formulaÇço farmacÊutica parenteral, e, processso para aumentar a estabilidade quÍmica de uma preparaÇço de insulina.
DE3852140D1 (de) Produktion von Proteinen in aktiven Formen.
ES2119779T3 (es) Solubilizacion de proteinas en formas activas.
DE69101634D1 (de) Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus.
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
FI870808L (fi) 9-alfa, 11-beta-substituerade och 11-beta-substituerade estraner.
ATE249841T1 (de) Immunogene zubereitungen
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
SE8700156D0 (sv) Kosmetiska kompositioner med hudlugnande och hudgenerande effekt och forfarande for framstellning derav
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
FI944907A0 (fi) Uusi antineoplastinen sytokiini
ATE123302T1 (de) Rhoptry-membran-antigen von -i(plasmodium falciparum).
ATE80143T1 (de) Isomere formyl-trimethylbicyclo(2,2,2)oct-7-ene.
BR9104547A (pt) Processo de curtimento de uma substancia proteica,substancia proteica curtida e agente de curtimento de proteinas
FR2623378B1 (fr) Gaine de maintien abdominale
ITFE930013U1 (it) Bacchette orientali meccanizzate.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 547102

Country of ref document: ES